(untitled)Christina Yau, Adam L. Asare, Jean Abraham et al.|Edinburgh Research Explorer|0Cited by 353
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Rachel Schiff, Huizhong Hu et al.|Clinical Cancer Research|2015Cited by 119
Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenograftsMiguel Martín, Sara López‐Tarruella|Scientific Reports|2021Cited by 30
Supplementary figure legend from Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Rachel Schiff, Huizhong Hu et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Rachel Schiff, Huizhong Hu et al.|Unknown|2023Cited by 0